Skip to main content
RT @jeffsparks: Large case-control study (n=8028) to identify baseline predictors of rheum irAEs after immune checkpoint

Jeffrey Sparks MD MMSc jeffsparks

4 years 10 months ago
Large case-control study (n=8028) to identify baseline predictors of rheum irAEs after immune checkpoint inhibitor initiation for cancer. Type of cancer (melanoma, GU), combination ICI, pre-existing autoimmune disease, and recent GC use each had higher odds of rheum irAE #ACR21 https://t.co/rHI6VQ37QB
RT @Janetbirdope: #ClinicalPearl Joint clinic btwn ophthalmology & #rheumatology helps make dx & Rx work. #ACRBe

Janet Pope Janetbirdope

4 years 10 months ago
#ClinicalPearl Joint clinic btwn ophthalmology & #rheumatology helps make dx & Rx work. #ACRBest #ACR21 see work up of inflammatory eyes disease. All are allowed one acute ant uveitis- ? dogma maybe work up all. 6S117 https://t.co/Wwdv3N66HS
RT @MeralElRamahiMD: #ACR21 Abst#0290:
Ever wonder about other predictors of mortality in pts w/ RA-Lung Disease beside

Meral K. El Ramahi, MD MeralElRamahiMD

4 years 10 months ago
#ACR21 Abst#0290: Ever wonder about other predictors of mortality in pts w/ RA-Lung Disease besides ILD (OR 2.3) or older age? ⭐︎ ↑ mortality associated w/ pleural effusions (OR 3.3) AND, notably... ⭐︎MTX use was protective (OR 0.4)!!! @RheumNow https://t.co/KKRkQVY2pf https://t.co/JsU2Rqzi6R
RT @RHEUMarampa: This study looked into the prevalence of subclinical atherosclerosis in #rheumatoidarthritis pts w/n 5

sheila RHEUMarampa

4 years 10 months ago
This study looked into the prevalence of subclinical atherosclerosis in #rheumatoidarthritis pts w/n 5 yrs of dx using carotid US. 📌vs. controls, RA pts had ⬆ CPs, cIMT ❗Screen RA pts for CV risk early on in their diagnosis @RheumNow #ACR21 abs0271 https://t.co/btU6IcM3xb
RT @uptoTate: ASAS-PerSpA worldwide study: axSpA most common SpA from in family hx. Except in Middle Eastern/N. African

Dr. Rachel Tate uptoTate

4 years 10 months ago
ASAS-PerSpA worldwide study: axSpA most common SpA from in family hx. Except in Middle Eastern/N. African pts, a FH of axSpA associated w/ +HLA-B27 in axSpA pts. PsO and IBD FH more likely -HLA-B27 . FH of ReA rare. Abs 0368 #ACR21 #RheumNow @RheumNow https://t.co/iHBccAcvLi https://t.co/FCoyVg3MGw
RT @ericdeinmd: #ACR21 Abst#0293
RA patients with lung disease have increased rates of SSc-specific autoantibodies compa

Eric Dein ericdeinmd

4 years 10 months ago
#ACR21 Abst#0293 RA patients with lung disease have increased rates of SSc-specific autoantibodies compared to RA w/o lung disease. ▶️ Suggests we may need to investigate further into overlap phenotype in RA-ILD @Rheumnow https://t.co/04FFuBUKmA https://t.co/A83kaie2gr
RT @Janetbirdope: #ClinicalPearl. ‘my eye hurts-what’s going on!’ Dr Palestine says Ophthalmologists don’t agree

Janet Pope Janetbirdope

4 years 10 months ago
#ClinicalPearl. ‘my eye hurts-what’s going on!’ Dr Palestine says Ophthalmologists don’t agree on uveitis naming/ethology & worse - Rheums & eye specialists don’t speak language. Need to know infections are r/o (syphillis, CXR) & if active uveitis to ⬆️Rx #ACR21 @RheumNow https://t.co/7LkhJnUKXK
RT @AurelieRheumo: We should aim for early treatment and good retention in ax-SpA to prevent structural evolution. >

Aurelie Najm AurelieRheumo

4 years 10 months ago
We should aim for early treatment and good retention in ax-SpA to prevent structural evolution. >12 months of TNFi treatment in the previous 2 years associated w/ ⬇️ radiographic progression of SIJ in r- and nr-axSpA in GESPIC, #Abst0174 @RheumNow #ACR21 https://t.co/2V1q4dUwFO https://t.co/lxQU4zAP1I
RT @uptoTate: Retrospective French study found adding JAKi may be helpful in refractory AOSD. No complete response noted

Dr. Rachel Tate uptoTate

4 years 10 months ago

Retrospective French study found adding JAKi may be helpful in refractory AOSD. No complete response noted and no beneficial effect as monotherapy. Possible difference between JAKi? Abs 0195 #ACR21 #RheumNow #ACRbest @RheumNow https://t.co/J8kLJpJ39o https://t.co/aVsfCQ8CyV

RT @RichardPAConway: Our latest article on outcomes of patients with vasculitis and PMR and COVID-19 published in @TheLa

Richard Conway RichardPAConway

4 years 10 months ago
Our latest article on outcomes of patients with vasculitis and PMR and COVID-19 published in @TheLancetRheum . @rheum_covid project with co-leads @SattuiSEMD and @EBRheum . https://t.co/8NTAafdYRA
RT @DrMiniDey: #Fatigue is common in pts w/ #PsA- what is the impact on short-term disability?

Study of ~1200 pts finds

Mrinalini Dey DrMiniDey

4 years 10 months ago
#Fatigue is common in pts w/ #PsA- what is the impact on short-term disability? Study of ~1200 pts finds greater annual short-term disability in pts with PsA & fatigue than w/o fatigue. Impact on QoL, work & socioeconomic costs. @RheumNow #ACR21 Abs#0239 https://t.co/9yNBOovm2L https://t.co/l4tn0TSld1
RT @RheumDr_Nina: 📌Pre-Test Probability in GCA

ESR/CRP can be normal:
~10% of pts at diagnosis
-20-40% at time or

Nina Couette RheumDr_Nina

4 years 10 months ago
📌Pre-Test Probability in GCA ESR/CRP can be normal: ~10% of pts at diagnosis -20-40% at time or relapse #ACR21 #ACRAmbassador #RheumTwitter https://t.co/kenaD31pYa
RT @bella_mehta: Machine learning predicted lupus nephritis in #SLE patients in real world data #ACR21 @RheumNow #abst03

Bella Mehta bella_mehta

4 years 10 months ago
Machine learning predicted lupus nephritis in #SLE patients in real world data #ACR21 @RheumNow #abst0324 https://t.co/67HBT7F2GO
RT @RichardPAConway: Dr Doliner @zach_wallace_md on ILD in AAV. ILD in 13% - of which 76% fibrotic. UIP most common. Mos

Richard Conway RichardPAConway

4 years 10 months ago
Dr Doliner @zach_wallace_md on ILD in AAV. ILD in 13% - of which 76% fibrotic. UIP most common. Most MPO+, but also rarely seen with PR3+. 47% ⬆️ risk of death. Abstr#0430 #ACR21 @RheumNow https://t.co/6MnxqW92bz
RT @RichardPAConway: Dr Preger report 9 novel aminoacyl tRNA synthetases in IIM patients. May these allow us to spare mo

Richard Conway RichardPAConway

4 years 10 months ago
Dr Preger report 9 novel aminoacyl tRNA synthetases in IIM patients. May these allow us to spare more patients biopsy? Abstr#0001 #ACR21 @RheumNow https://t.co/ikNXCEOeuj
×